These final results, together with a previous report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the concept of targeting ACKR3 as a novel method to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-similar Ailments. (two) The health practitioner https://chickb567cqb2.wssblogs.com/profile